Download - Sepsis neo precoz

DOI: 10.1542/peds.2012-0541; originally published online April 30, 2012; 2012;129;1006Pediatrics

Richard A. Polin and the COMMITTEE ON FETUS AND NEWBORNSepsis

Management of Neonates With Suspected or Proven Early-Onset Bacterial

http://pediatrics.aappublications.org/content/129/5/1006.full.html

located on the World Wide Web at: The online version of this article, along with updated information and services, is

of Pediatrics. All rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.Boulevard, Elk Grove Village, Illinois, 60007. Copyright © 2012 by the American Academy published, and trademarked by the American Academy of Pediatrics, 141 Northwest Pointpublication, it has been published continuously since 1948. PEDIATRICS is owned, PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly

at Hacettepe University on May 9, 2012pediatrics.aappublications.orgDownloaded from


http://pediatrics.aappublications.org/

CLINICAL REPORT

Management of Neonates With Suspected or ProvenEarly-Onset Bacterial Sepsis

abstractWith improved obstetrical management and evidence-based use ofintrapartum antimicrobial therapy, early-onset neonatal sepsis is be-coming less frequent. However, early-onset sepsis remains one of themost common causes of neonatal morbidity and mortality in the pre-term population. The identification of neonates at risk for early-onsetsepsis is frequently based on a constellation of perinatal risk factorsthat are neither sensitive nor specific. Furthermore, diagnostic testsfor neonatal sepsis have a poor positive predictive accuracy. As a result,clinicians often treat well-appearing infants for extended periods of time,even when bacterial cultures are negative. The optimal treatment ofinfants with suspected early-onset sepsis is broad-spectrum antimicro-bial agents (ampicillin and an aminoglycoside). Once a pathogen is iden-tified, antimicrobial therapy should be narrowed (unless synergism isneeded). Recent data suggest an association between prolonged empir-ical treatment of preterm infants (≥5 days) with broad-spectrum anti-biotics and higher risks of late onset sepsis, necrotizing enterocolitis,and mortality. To reduce these risks, antimicrobial therapy should bediscontinued at 48 hours in clinical situations in which the probabilityof sepsis is low. The purpose of this clinical report is to provide apractical and, when possible, evidence-based approach to the manage-ment of infants with suspected or proven early-onset sepsis. Pediatrics2012;129:1006–1015

INTRODUCTION

“Suspected sepsis” is one of the most common diagnoses made in theNICU.1 However, the signs of sepsis are nonspecific, and inflammatorysyndromes of noninfectious origin mimic those of neonatal sepsis. Mostinfants with suspected sepsis recover with supportive care (with orwithout initiation of antimicrobial therapy). The challenges for cliniciansare threefold: (1) identifying neonates with a high likelihood of sepsispromptly and initiating antimicrobial therapy; (2) distinguishing “high-risk” healthy-appearing infants or infants with clinical signs who do notrequire treatment; and (3) discontinuing antimicrobial therapy oncesepsis is deemed unlikely. The purpose of this clinical report is toprovide a practical and, when possible, evidence-based approach to thediagnosis and management of early-onset sepsis, defined by the Na-tional Institute of Child Health and Human Development and VermontOxford Networks as sepsis with onset at ≤3 days of age.

Richard A. Polin, MD and the COMMITTEE ON FETUS ANDNEWBORN

KEY WORDSearly-onset sepsis, antimicrobial therapy, group B streptococcus,meningitis, gastric aspirate, tracheal aspirate, chorioamnionitis,sepsis screen, blood culture, lumbar puncture, urine culture,body surface cultures, white blood count, acute phase reactants,prevention strategies

ABBREVIATIONSCFU—colony-forming unitsCRP—C-reactive proteinCSF—cerebrospinal fluidGBS—group B streptococciI/T—immature to total neutrophil (ratio)PMN—polymorphonuclear leukocytePPROM—preterm premature rupture of membranes

This document is copyrighted and is property of the AmericanAcademy of Pediatrics and its Board of Directors. All authorshave filed conflict of interest statements with the AmericanAcademy of Pediatrics. Any conflicts have been resolved througha process approved by the Board of Directors. The AmericanAcademy of Pediatrics has neither solicited nor accepted anycommercial involvement in the development of the content ofthis publication.

The guidance in this report does not indicate an exclusivecourse of treatment or serve as a standard of medical care.Variations, taking into account individual circumstances, may beappropriate.

www.pediatrics.org/cgi/doi/10.1542/peds.2012-0541

doi:10.1542/peds.2012-0541

All clinical reports from the American Academy of Pediatricsautomatically expire 5 years after publication unless reaffirmed,revised, or retired at or before that time.

PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275).

Copyright © 2012 by the American Academy of Pediatrics

1006 FROM THE AMERICAN ACADEMY OF PEDIATRICS

Guidance for the Clinician inRendering Pediatric Care



PATHOGENESIS ANDEPIDEMIOLOGY OF EARLY-ONSETSEPSIS

Before birth, the fetus optimally ismaintained in a sterile environment.Organisms causing early-onset sepsisascend from the birth canal eitherwhen the amniotic membranes ruptureor leak before or during the course oflabor, resulting in intra-amniotic infec-tion.2 Commonly referred to as “cho-rioamnionitis,” intra-amniotic infectionindicates infection of the amniotic fluid,membranes, placenta, and/or decidua.

Group B streptococci (GBS) can alsoenter the amniotic fluid through occulttears. Chorioamnionitis is a major riskfactor for neonatal sepsis. Sepsis canbegin in utero when the fetus inhalesor swallows infected amniotic fluid.The neonate can also develop sepsis inthe hours or days after birth whencolonized skin or mucosal surfaces arecompromised. The essential criterionfor the clinical diagnosis of chorio-amnionitis is maternal fever. Othercriteria are relatively insensitive. Whendefining intra-amniotic infection (cho-rioamnionitis) for clinical researchstudies, the diagnosis is typically basedon the presence of maternal fever ofgreater than 38°C (100.4°F) and at leasttwo of the following criteria: maternalleukocytosis (greater than 15 000 cells/mm3), maternal tachycardia (greaterthan 100 beats/minute), fetal tachycar-dia (greater than 160 beats/minute),uterine tenderness, and/or foul odor ofthe amniotic fluid. These thresholds areassociated with higher rates of neo-natal and maternal morbidity.

Nonetheless, the diagnosis of cho-rioamnionitis must be considered evenwhen maternal fever is the sole abnor-mal finding. Although fever is commonin women who receive epidural anes-thesia (15%–20%), histologic evidenceof acute chorioamnionitis is very com-mon in women who become febrileafter an epidural (70.6%).3 Furthermore,

most of these women with histologicchorioamnionitis do not have a positiveplacental culture.3 The incidence of clin-ical chorioamnionitis varies inverselywith gestational age. In the NationalInstitute of Child Health and HumanDevelopment Neonatal Research Net-work, 14% to 28% of women deliveringpreterm infants at 22 through 28 weeks’gestation exhibited signs compatiblewith chorioamnionitis.4 The major riskfactors for chorioamnionitis includelow parity, spontaneous labor, longerlength of labor and membrane rupture,multiple digital vaginal examinations(especially with ruptured membranes),meconium-stained amniotic fluid, internalfetal or uterine monitoring, and pres-ence of genital tract microorganisms(eg, Mycoplasma hominis).5

At term gestation, less than 1% ofwomen with intact membranes willhave organisms cultured from amni-otic fluid.6 The rate can be higher ifthe integrity of the amniotic cavity iscompromised by procedures beforebirth (eg, placement of a cerclage oramniocentesis).6 In women with pre-term labor and intact membranes, therate of microbial invasion of the amni-otic cavity is 32%, and if there is pre-term premature rupture of membranes(PPROM), the rate may be as high as75%.7 Many of the pathogens recoveredfrom amniotic fluid in women with pre-term labor or PPROM (eg, Ureaplasmaspecies or Mycoplasma species) donot cause early-onset sepsis.8–10 How-ever, both Ureaplasma and Myco-plasma organisms can be recoveredfrom the bloodstream of infants whosebirth weight is less than 1500 g.11 Whena pathogen (eg, GBS) is recovered fromamniotic fluid, the attack rate of neo-natal sepsis can be as high as 20%.12

Infants born to women with PPROMwho are colonized with GBS have anestimated attack rate of 33% to 50%when intrapartum prophylaxis is notgiven.13

The major risk factors for early-onsetneonatal sepsis are preterm birth,maternal colonization with GBS, ruptureof membranes >18 hours, and mater-nal signs or symptoms of intra-amnioticinfection.14–16 Other variables includeethnicity (ie, black women are at higherrisk of being colonized with GBS), lowsocioeconomic status, male sex, andlow Apgar scores. Preterm birth/lowbirth weight is the risk factor mostclosely associated with early-onset sep-sis.17 Infant birth weight is inverselyrelated to risk of early-onset sepsis.The increased risk of early-onset sep-sis in preterm infants is also related tocomplications of labor and deliveryand immaturity of innate and adaptiveimmunity.18

DIAGNOSTIC TESTING FOR SEPSIS

The clinical diagnosis of sepsis in theneonate is difficult, because many ofthe signs of sepsis are nonspecific andare observed with other noninfectiousconditions. Although a normal physicalexamination is evidence that sepsis isnot present,19,20 bacteremia can occurin the absence of clinical signs.21 Avail-able diagnostic testing is not helpful indeciding which neonate requires em-pirical antimicrobial therapy but canassist with the decision to discontinuetreatment.22

Blood Culture

A single blood culture in a sufficientvolume is required for all neonateswith suspected sepsis. Data suggestthat 1.0 mL of blood should be theminimum volume drawn for culturewhen a single pediatric blood culturebottle is used. Dividing the specimen inhalf and inoculating aerobic and an-aerobic bottles is likely to decrease thesensitivity. Although 0.5 mL of bloodhas previously been considered ac-ceptable, in vitro data from Schelonkaet al demonstrated that 0.5 mL wouldnot reliably detect low-level bacteremia

PEDIATRICS Volume 129, Number 5, May 2012 1007

FROM THE AMERICAN ACADEMY OF PEDIATRICS



(4 colony-forming units [CFU]/mL orless).23 Furthermore, up to 25% ofinfants with sepsis have low colonycount bacteremia (≤4 CFU/mL), andtwo-thirds of infants younger than 2months of age have colony counts <10CFU/mL.24,25 Neal et al demonstratedthat more than half of blood specimensinoculated into the aerobic bottle wereless than 0.5 mL.26 A study by Connellet al indicated that blood cultures withan adequate volume were twice aslikely to yield a positive result.27 A bloodculture obtained through an umbilicalartery catheter shortly after placementfor other clinical indications is an ac-ceptable alternative to a culture drawnfrom a peripheral vein.28 The risk ofrecovering a contaminant is greaterwith a blood culture drawn from anumbilical vein.29 There are, however,data to suggest that a blood culturedrawn from the umbilical vein at thetime of delivery using a doubly clam-ped and adequately prepared segmentof the cord is a reliable alternative toa culture obtained peripherally.30

Urine Culture

A urine culture should not be part of thesepsisworkup in an infant with suspectedearly-onset sepsis.31 Unlike urinary tractinfections in older infants (which areusually ascending infections), urinarytract infections in newborn infants areattributable to seeding of the kidneyduring an episode of bacteremia.

Gastric Aspirates

The fetus swallows 500 to 1000 mL ofamniotic fluid each day. Therefore, ifthere are white blood cells present inamniotic fluid, they will be present ingastric aspirate specimens at birth.However, these cells represent the ma-ternal response to inflammation andhave a poor correlation with neonatalsepsis.32 Gram stains of gastric aspiratesto identify bacteria are of limited valueand are not routinely recommended.33

Body Surface Cultures

Bacterial cultures of the axilla, groin,and the external ear canal have a poorpositive predictive accuracy. They areexpensive and add little to the evalu-ation of an infant with possible bac-terial sepsis.34,35

Tracheal Aspirates

Cultures and Gram stains of trachealaspirate specimens may be of value ifobtained immediately after endotra-cheal tube placement.36 Once an infanthas been intubated for several days,tracheal aspirates are of no value inthe evaluation of sepsis.37

Lumbar Puncture

The decision to perform a lumbar punc-ture in a neonate with suspected early-onset sepsis remains controversial. Inthe high-risk, healthy-appearing in-fant, data suggest that the likelihoodof meningitis is extremely low.38 In theinfant with clinical signs that are thoughtto be attributable to a noninfectiouscondition, such as respiratory distresssyndrome, the likelihood of meningitisis also low.39 However, in bacteremicinfants, the incidence of meningitis maybe as high as 23%.40,41 Blood culturealone cannot be used to decide whoneeds a lumbar puncture, becauseblood cultures can be negative in upto 38% of infants with meningitis.42,43

The lumbar puncture should be per-formed in any infant with a positiveblood culture, infants whose clinicalcourse or laboratory data stronglysuggest bacterial sepsis, and infantswho initially worsen with antimicro-bial therapy. For any infant who iscritically ill and likely to have cardio-vascular or respiratory compromisefrom the procedure, the lumbar punc-ture can be deferred until the infant ismore stable.

Cerebrospinal fluid (CSF) values indic-ative of neonatal meningitis are con-troversial. In studies that have excluded

infants with “traumatic taps” (ornonbacterial illnesses), the meannumber of white blood cells in un-infected preterm or term infants wasconsistently <10 cells/mm3.44–50 Cellcounts 2 standard deviations from themean were generally less than 20cells/mm3.46 In a study by Garges et al,the median number of white blood cellsin infants who were born at greaterthan 34 weeks’ gestation and hadbacterial meningitis was 477/mm3.43

In contrast, the median number of whiteblood cells in infants who were born atless than 34 weeks’ gestation and hadmeningitis was 110/mm3.51 Infants withmeningitis attributable to Gram-negativepathogens typically have higher CSFwhite blood cell counts than do infantswith meningitis attributable to Gram-positive pathogens.52 Adjusting theCSF white blood cell count for thenumber of red blood cells does notimprove the diagnostic utility (loss ofsensitivity with marginal gain in speci-ficity).53 In addition, the number of bandsin a CSF specimen does not predictmeningitis.54 With a delay in analysis(>2 hours), white blood cell countsand glucose concentrations decreasesignificantly.55

Protein concentrations in uninfected,term newborn infants are <100 mg/dL.44–50 Preterm infants have CSF pro-tein concentrations that vary inverselywith gestational age. In the normogly-cemic newborn infant, glucose con-centrations in CSF are similar to thosein older infants and children (70%–80%of a simultaneously obtained bloodspecimen). A low glucose concentrationis the CSF variable with the greatestspecificity for the diagnosis of menin-gitis.43,51 Protein concentrations arehigher and glucose concentrations arelower in term than in preterm infantswith meningitis. However, meningitisoccurs in infants with normal CSFvalues, and some of these infants havehigh bacterial inocula.43,51

1008 FROM THE AMERICAN ACADEMY OF PEDIATRICS at Hacettepe University on May 9, 2012pediatrics.aappublications.orgDownloaded from


Peripheral White Blood Cell Countand Differential Count

Total white blood cell counts have littlevalue in the diagnosis of early-onsetsepsis and have a poor positive pre-dictive accuracy.56,57 Many investi-gators have analyzed subcomponentsof the white blood cell count (neutrophilindices)—absolute neutrophil count,absolute band count, and immature tototal neutrophil (I/T)ratio—to identifyinfected infants. Like most diagnostictests for neonatal sepsis, neutrophil in-dices have proven most useful for ex-cluding infants without infection ratherthan identifying infected neonates. Neu-tropenia may be a better marker forneonatal sepsis and has better speci-ficity than an elevated neutrophil count,because few conditions besides sepsis(maternal pregnancy-induced hyper-tension, asphyxia, and hemolytic dis-ease) depress the neutrophil count ofneonates.58 The definitions for neutro-penia vary with gestational age,58–61

type of delivery (infants born by cesar-ean delivery without labor have lowercounts than infants delivered vagi-nally),61 site of sampling (neutrophilcounts are lower in samples fromarterial blood),62 and altitude (infantsborn at elevated altitudes have highertotal neutrophil counts).63 In late pre-term and term infants, the definitionfor neutropenia most commonly usedis that suggested by Manroe et al(<1800/mm3 at birth and <7800/mm3

at 12–14 hours of age).58 Schmutz et alreinvestigated these reference rangesusing modern cell-counting instrumen-tation in 30 254 infants born at 23 to 42weeks’ gestation.61 Infants with diagnosesknown to affect neutrophil counts (eg,those born to women with pregnancy-induced hypertension or those withearly-onset sepsis) were excluded. Inthis study, the lower limits of normalfor neutrophil values at birth were3500/mm3 in infants born at >36 weeks’gestation, 1000/mm3 in infants born at

28 through 36 weeks’ gestation, and500/mm3 in infants born at <28 weeks’gestation. Peak values occurred at 6 to8 hours after birth; the lower limits ofnormal at that time were 7500/mm3,3500/mm3, and 1500/mm3 for infantsborn at >36 weeks’ gestation, 28 to36 weeks’ gestation, and <28 weeks’gestation, respectively.61 It is notewor-thy that the study by Schmutz et al wasperformed at 4800 feet above sea level,whereas that of Manroe et al was per-formed at 500 feet above sea level.

The absolute immature neutrophil countfollows a similar pattern to the absoluteneutrophil count and peaks at approx-imately 12 hours of life. The number ofimmature neutrophils increases from amaximal value of 1100 cells/mm3 atbirth to 1500 cells/mm3 at 12 hours ofage.58 Absolute immature counts havea poor sensitivity and positive predic-tive accuracy for early-onset sepsis.22

Furthermore, if exhaustion of bone mar-row reserves occurs, the number of im-mature forms will remain depressed.64

The I/T ratio has the best sensitivity ofany of the neutrophil indices. However,with manual counts, there are wideinterreader differences in band neu-trophil identification.65 The I/T ratio is<0.22 in 96% of healthy preterm infantsborn at <32 weeks’ gestational age.66

Unlike the absolute neutrophil countand the absolute band count, maximumnormal values for the I/T ratio occur atbirth (0.16) and decline with increasingpostnatal age to a minimum value of0.12.58 In healthy term infants, the 90thpercentile for the I/T ratio is 0.27.59

A single determination of the I/T ratiohas a poor positive predictive accuracy(approximately 25%) but a very highnegative predictive accuracy (99%).66

The I/T ratio may be elevated in 25% to50% of uninfected infants.67

Exhaustion of bone marrow reserveswill result in low band counts and leadto falsely low ratios. The timing of thewhite blood cell count is critical.68

Counts obtained 6 to 12 hours afterbirth are more likely to be abnormalthan are counts obtained at birth, be-cause alterations in the numbers (andratios) of mature and immature neutro-phils require an established inflammatoryresponse. Therefore, once the decision ismade to start antimicrobial therapysoon after birth, it is worth waiting 6 to12 hours before ordering a white bloodcell count and differential count.68,69

Platelet Counts

Despite the frequency of low plateletcounts in infected infants, they are anonspecific, insensitive, and late indica-tor of sepsis.70,71 Moreover, plateletcounts are not useful to follow clinicalresponse to antimicrobial agents, be-cause they often remain depressed fordays to weeks after a sepsis episode.

Acute-Phase Reactants

A wide variety of acute-phase reactantshave been evaluated in neonates withsuspected bacterial sepsis. However, onlyC-reactive protein (CRP) and procalcito-nin concentrations have been investiga-ted in sufficiently large studies.72,73 CRPconcentration increases within 6 to 8hours of an infectious episode in neo-nates and peaks at 24 hours.74,75 Thesensitivity of a CRP determination islow at birth, because it requires aninflammatory response (with releaseof interleukin-6) to increase CRP con-centrations.76 The sensitivity improvesdramatically if the first determinationis made 6 to 12 hours after birth. Benitzet al have demonstrated that excludinga value at birth, 2 normal CRP deter-minations (8–24 hours after birth and24 hours later) have a negative pre-dictive accuracy of 99.7% and a nega-tive likelihood ratio of 0.15 for provenneonatal sepsis.76 If CRP determina-tions remain persistently normal, it isstrong evidence that bacterial sepsis isunlikely, and antimicrobial agents can besafely discontinued. Data are insufficientto recommend following sequential CRP





concentrations to determine the dura-tion of antimicrobial therapy in an infantwith an elevated value (≥1.0 mg/dL).Procalcitonin concentrations increasewithin 2 hours of an infectious episode,peak at 12 hours, and normalize within2 to 3 days in healthy adult volunteers.77

A physiologic increase in procalcitoninconcentration occurs within the first24 hours of birth, and an increase inserum concentrations can occur withnoninfectious conditions (eg, respira-tory distress syndrome).78 Procalcitoninconcentration has a modestly bettersensitivity than does CRP concentrationbut is less specific.73 Chiesa and col-leagues have published normal valuesfor procalcitonin concentrations in termand preterm infants.79 There is evidencefrom studies conducted in adult pop-ulations, the majority of which focusedon patients with sepsis in the ICU, thatsignificant reductions in use of anti-microbial agents can be achieved inpatients whose treatment is guided byprocalcitonin concentration.80

Sepsis Screening Panels

Hematologic scoring systems usingmultiple laboratory values (eg, whiteblood cell count, differential count, andplatelet count) have been recommen-ded as useful diagnostic aids. No matterwhat combination of tests is used, thepositive predictive accuracy of scoringsystems is poor unless the score isvery high. Rodwell et al described ascoring system in which a score of 1 wasassigned to 1 of 7 findings, includingabnormalities of leukocyte count, totalneutrophil count, increased immaturepolymorphonuclear leukocyte (PMN)count, increased I/T ratio, immature tomature PMN ratio >0.3, platelet count≤150 000/mm3, and pronounced degen-erative changes (ie, toxic granulations)in PMNs.81 In this study, two-thirdsof preterm infants and 90% of terminfants with a hematologic score≥3 did not have proven sepsis.81

Furthermore, scores obtained in thefirst several hours after birth have beenshown to have poorer sensitivity andnegative predictive value than scoresobtained at 24 hours of age.67 Sepsisscreening panels commonly includeneutrophil indices and acute-phase re-actants (usually CRP concentration). Thepositive predictive value of the sepsisscreen in neonates is poor (<30%);however, the negative predictive accuracyhas been high (>99%) in small clinicalstudies.22 Sepsis screening tests might beof value in deciding which “high-risk”healthy-appearing neonates do not needantimicrobial agents or whether therapycan be safely discontinued.

TREATMENT OF INFANTS WITHSUSPECTED EARLY-ONSET SEPSIS

In the United States, the most commonpathogens responsible for early-onsetneonatal sepsis are GBS and Escherichiacoli.17 A combination of ampicillin andan aminoglycoside (usually gentamicin)is generally used as initial therapy, andthis combination of antimicrobial agentsalso has synergistic activity againstGBS and Listeria monocytogenes.82,83

Third-generation cephalosporins (eg,cefotaxime) represent a reasonable al-ternative to an aminoglycoside. However,several studies have reported rapiddevelopment of resistance when cefo-taxime has been used routinely for thetreatment of early-onset neonatal sep-sis,84 and extensive/prolonged use ofthird-generation cephalosporins is a riskfactor for invasive candidiasis.85 Be-cause of its excellent CSF penetration,empirical or therapeutic use of cefo-taxime should be restricted for use ininfants with meningitis attributable toGram-negative organisms.86 Ceftriax-one is contraindicated in neonatesbecause it is highly protein boundand may displace bilirubin, leading to arisk of kernicterus. Bacteremia without anidentifiable focus of infection is generallytreated for 10 days.87 Uncomplicated

meningitis attributable to GBS is trea-ted for a minimum of 14 days.88 Otherfocal infections secondary to GBS (eg,cerebritis, osteomyelitis, endocarditis)are treated for longer durations.88 Gram-negative meningitis is treated forminimum of 21 days or 14 days afterobtaining a negative culture, whicheveris longer.88 Treatment of Gram-negativemeningitis should include cefotaximeand an aminoglycoside until the resultsof susceptibility testing are known.87,88

The duration of antimicrobial therapyin infants with negative blood culturesis controversial. Many women receiveantimicrobial agents during labor asprophylaxis to prevent early-onset GBSinfections or for management of sus-pected intra-amniontic infection orPPROM. In those instances, postnatalblood cultures may be sterile (falsenegative). When considering the dura-tion of therapy in infants with negativeblood cultures, the decision shouldinclude consideration of the clinicalcourse as well as the risks associatedwith longer courses of antimicrobialagents. In a retrospective study by Cor-dero and Ayers, the average duration oftreatment in 695 infants (<1000 g)with negative blood cultures was 5 ±3 days.89 Cotten et al have suggestedan association with prolonged adminis-tration of antimicrobial agents (>5 days)in infants with suspected early-onsetsepsis (and negative blood cultures)with death and necrotizing enterocoli-tis.90 Two recent papers also supportthis association.91,92

PREVENTION STRATEGIES FOREARLY-ONSET SEPSIS

The only intervention proven to decreasethe incidence of early-onset neonatalsepsis is maternal treatment withintrapartum intravenous antimicro-bial agents for the prevention of GBSinfections.93 Adequate prophylaxis isdefined as penicillin (the preferredagent), ampicillin, or cefazolin given for



≥4 hours before delivery. Erythromycinis no longer recommended for prophy-laxis because of high resistance rates.In parturients who have a nonseriouspenicillin allergy, cefazolin is the drugof choice. For parturients with a historyof serious penicillin allergy (anaphy-laxis, angioedema, respiratory com-promise, or urticaria), clindamycin isan acceptable alternative agent, butonly if the woman’s rectovaginal GBSscreening isolate has been tested anddocumented to be susceptible. If theclindamycin susceptibility is unknownor the GBS isolate is resistant to clin-damycin, vancomycin is an alternativeagent for prophylaxis. However, nei-ther clindamycin nor vancomycin hasbeen evaluated for efficacy in pre-venting early-onset GBS sepsis inneonates. Intrapartum antimicrobialagents are indicated for the followingsituations93:

1. Positive antenatal cultures or molec-ular test at admission for GBS (ex-cept for women who have a cesareandelivery without labor or membranerupture)

2. Unknown maternal colonization sta-tus with gestation <37 weeks, rup-ture of membranes >18 hours, ortemperature >100.4°F (>38°C)

3. GBS bacteriuria during the currentpregnancy

4. Previous infant with invasive GBSdisease

Management guidelines for the new-born infant have been published93 andare available online (http://www.cdc.gov/groupbstrep/guidelines/index.html).

CLINICAL CHALLENGES

Challenge 1: Identifying NeonatesWith Clinical Signs of Sepsis Witha “High Likelihood” of Early-OnsetSepsis Who Require AntimicrobialAgents Soon After Birth

Most infants with early-onset sepsisexhibit abnormal signs in the first 24

hours of life. Approximately 1% of infantswill appear healthy at birth and thendevelop signs of infection after a vari-able time period.21 Every critically illinfant should be evaluated and receiveempirical broad-spectrum antimicrobialtherapy after cultures, even when thereare no obvious risk factors for sepsis.The greatest difficulty faced by clini-cians is distinguishing neonates withearly signs of sepsis from neonateswith noninfectious conditions with rel-atively mild findings (eg, tachypnea withor without an oxygen requirement). Inthis situation, data are insufficient toguide management. In more matureneonates without risk factors for in-fection who clinically improve over thefirst 6 hours of life (eg, need for oxygenis decreasing and respiratory distressis resolving), it is reasonable to with-hold antimicrobial therapy and monitorthe neonates closely. The 6-hour win-dow should not be considered absolute;however, most infants without infec-tion demonstrate some improvementover that time period. Any worsening ofthe infant’s condition should prompt

starting antimicrobial agents after cul-tures have been obtained.

Challenge 2: IdentifyingHealthy-Appearing Neonates Witha “High Likelihood” of Early-OnsetSepsis Who Require AntimicrobialAgents Soon After Birth

This category includes infants with 1 ofthe risk factors for sepsis noted pre-viously (colonization with GBS, prolongedrupture of membranes >18 hours, ormaternal chorioamnionitis). GBS is nota risk factor if the mother has receivedadequate intrapartum therapy (penicil-lin, ampicillin, or cefazolin for at least4 hours before delivery) or has a ce-sarean delivery with intact membranesin the absence of labor.93 The risk ofinfection in the newborn infant variesconsiderably with the risk factor pres-ent. The greatest risk of early-onsetsepsis occurs in infants born to womenwith chorioamnionitis who are alsocolonized with GBS and did not receiveintrapartum antimicrobial agents. Early-onset sepsis does occur in infants whoappear healthy at birth.21 Therefore,

FIGURE 1Evaluation of asymptomatic infants <37 weeks’ gestation with risk factors for sepsis. aThe diagnosisof chorioamnionitis is problematic and has important implications for the management of thenewborn infant. Therefore, pediatric providers are encouraged to speak with their obstetricalcolleagues whenever the diagnosis is made. bLumbar puncture is indicated in any infant witha positive blood culture or in whom sepsis is highly suspected on the basis of clinical signs, re-sponse to treatment, and laboratory results. IAP, intrapartum antimicrobial prophylaxis; WBC, whiteblood cell; Diff, differential white blood cell count.




http://www.cdc.gov/groupbstrep/guidelines/index.html

http://www.cdc.gov/groupbstrep/guidelines/index.html


some clinicians use diagnostic testswith a high negative predictive accuracyas reassurance that infection is notpresent (allowing them to withholdantimicrobial agents). The decision ofwhether to treat a high-risk infantdepends on the risk factors present,the frequency of observations, andgestational age. The threshold for

initiating antimicrobial treatment gen-erally decreases with increasing num-bers of risk factors for infection andgreater degrees of prematurity. Sug-gested algorithms for management ofhealthy-appearing, high-risk infants areshown in Figs 1, 2, and 3. Screeningblood cultures have not been shown tobe of value.21

CONCLUSIONS

The diagnosis and management of neo-nates with suspected early-onset sepsisare based on scientific principles mod-ified by the “art and experience” of thepractitioner. The following are well-established concepts related to neo-natal sepsis:

1. Neonatal sepsis is a major cause ofmorbidity and mortality.

2. Diagnostic tests for early-onsetsepsis (other than blood or CSF cul-tures) are useful for identifying in-fants with a low probability of sepsisbut not at identifying infants likely tobe infected.

3. One milliliter of blood drawn beforeinitiating antimicrobial therapy isneeded to adequately detect bacter-emia if a pediatric blood culture bot-tle is used.

4. Cultures of superficial body sites,gastric aspirates, and urine are ofno value in the diagnosis of early-onset sepsis.

5. Lumbar puncture is not needed inall infants with suspected sepsis (es-pecially those who appear healthy)but should be performed for infantswith signs of sepsis who can safelyundergo the procedure, for infantswith a positive blood culture, for in-fants likely to be bacteremic (on thebasis of laboratory data), and infantswho do not respond to antimicrobialtherapy in the expected manner.

6. The optimal treatment of infants withsuspected early-onset sepsis isbroad-spectrum antimicrobial agents(ampicillin and an aminoglycoside).Once the pathogen is identified,antimicrobial therapy should benarrowed (unless synergism isneeded).

7. Antimicrobial therapy should bediscontinued at 48 hours in clinicalsituations in which the probabilityof sepsis is low.

FIGURE 2Evaluation of asymptomatic infants ≥37 weeks’ gestation with risk factors for sepsis. aThe diagnosisof chorioamnionitis is problematic and has important implications for the management of thenewborn infant. Therefore, pediatric providers are encouraged to speak with their obstetricalcolleagues whenever the diagnosis is made. bLumbar puncture is indicated in any infant witha positive blood culture or in whom sepsis is highly suspected on the basis of clinical signs, re-sponse to treatment, and laboratory results. WBC, white blood cell; Diff, differential white blood cellcount.

FIGURE 3Evaluation of asymptomatic infants ≥37 weeks’ gestation with risk factors for sepsis (nochorioamnionitis). aInadequate treatment: Defined as the use of an antibiotic other than penicillin,ampicillin, or cefazolin or if the duration of antibiotics before delivery was <4 h. bDischarge at 24 his acceptable if other discharge criteria have been met, access to medical care is readily accessible,and a person who is able to comply fully with instructions for home observation will be present. Ifany of these conditions is not met, the infant should be observed in the hospital for at least 48 h anduntil discharge criteria are achieved. IAP, intrapartum antimicrobial prophylaxis; WBC, white bloodcell; Diff, differential white blood cell count.



LEAD AUTHORRichard A. Polin, MD

COMMITTEE ON FETUS ANDNEWBORN, 2011–2012Lu-Ann Papile, MD, ChairpersonJill E. Baley, MDWilliam Benitz, MDWaldemar A. Carlo, MDJames Cummings, MDPraveen Kumar, MDRichard A. Polin, MD

Rosemarie C. Tan, MD, PhDKasper S. Wang, MDKristi L. Watterberg, MD

FORMER COMMITTEE MEMBERVinod K. Bhutani, MD

LIAISONSCAPT Wanda Denise Barfield, MD, MPH – Centersfor Disease Control and PreventionGeorge Macones, MD – American College ofObstetricians and Gynecologists

Ann L. Jefferies, MD – Canadian Paediatric SocietyRosalie O. Mainous, PhD, RNC, NNP – NationalAssociation of Neonatal NursesTonse N. K. Raju, MD, DCH – National Institutesof Health

FORMER LIAISONWilliam Barth, Jr, MD – American College ofObstetricians and Gynecologists

STAFFJim Couto, MA

REFERENCES

1. Escobar GJ. The neonatal “sepsis work-up”:personal reflections on the development ofan evidence-based approach toward newborninfections in a managed care organization.Pediatrics. 1999;103(1, suppl E):360–373

2. Polin RA, St Geme JW III. Neonatal sepsis.Adv Pediatr Infect Dis. 1992;7:25–61

3. Riley LE, Celi AC, Onderdonk AB, et al. Asso-ciation of epidural-related fever and non-infectious inflammation in term labor. ObstetGynecol. 2011;117(3):588–595

4. Stoll BJ, Hansen NI, Bell EF, et al; EuniceKennedy Shriver National Institute of ChildHealth and Human Development NeonatalResearch Network. Neonatal outcomes ofextremely preterm infants from the NICHDNeonatal Research Network. Pediatrics.2010;126(3):443–456

5. Tita AT, Andrews WW. Diagnosis and man-agement of clinical chorioamnionitis. ClinPerinatol. 2010;37(2):339–354

6. Gibbs RS, Duff P. Progress in pathogenesisand management of clinical intraamnioticinfection. Am J Obstet Gynecol. 1991;164(5pt 1):1317–1326

7. Romero R, Quintero R, Oyarzun E, et al.Intraamniotic infection and the onset oflabor in preterm premature rupture of themembranes. Am J Obstet Gynecol. 1988;159(3):661–666

8. DiGiulio DB, Romero R, Kusanovic JP, et al.Prevalence and diversity of microbes in theamniotic fluid, the fetal inflammatory response,and pregnancy outcome in women with pre-term pre-labor rupture of membranes. Am JReprod Immunol. 2010;64(1):38–57

9. DiGiulio DB, Romero R, Amogan HP, et al.Microbial prevalence, diversity and abun-dance in amniotic fluid during pretermlabor: a molecular and culture-based in-vestigation. PLoS ONE. 2008;3(8):e3056

10. Viscardi RM. Ureaplasma species: role indiseases of prematurity. Clin Perinatol.2010;37(2):393–409

11. Goldenberg RL, Andrews WW, Goepfert AR,et al The Alabama Preterm Birth Study:umbilical cord blood Ureaplasma ure-alyticum and Mycoplasma hominis cul-tures in very preterm newborn infants.Am J Obstet Gynecol. 2008;198(1):43.e1–43.e5

12. Benitz WE, Gould JB, Druzin ML. Risk factorsfor early-onset group B streptococcal sep-sis: estimation of odds ratios by criticalliterature review. Pediatrics. 1999;103(6).Available at: www.pediatrics.org/cgi/content/full/103/6/e77

13. Newton ER, Clark M. Group B streptococcusand preterm rupture of membranes. ObstetGynecol. 1988;71(2):198–202

14. Schuchat A, Zywicki SS, Dinsmoor MJ, et al.Risk factors and opportunities for preven-tion of early-onset neonatal sepsis: a multi-center case-control study. Pediatrics. 2000;105(1 pt 1):21–26

15. Schrag SJ, Hadler JL, Arnold KE, Martell-Cleary P, Reingold A, Schuchat A. Risk fac-tors for invasive, early-onset Escherichiacoli infections in the era of widespreadintrapartum antibiotic use. Pediatrics. 2006;118(2):570–576

16. Martius JA, Roos T, Gora B, et al. Risk fac-tors associated with early-onset sepsis inpremature infants. Eur J Obstet GynecolReprod Biol. 1999;85(2):151–158

17. Stoll BJ, Hansen NI, Sánchez PJ, et al;Eunice Kennedy Shriver National Institute ofChild Health and Human Development Neo-natal Research Network. Early onset neonatalsepsis: the burden of group B Streptococcaland E. coli disease continues. Pediatrics.2011;127(5):817–826

18. Wynn JL, Levy O. Role of innate hostdefenses in susceptibility to early-onsetneonatal sepsis. Clin Perinatol. 2010;37(2):307–337

19. Escobar GJ, Li DK, Armstrong MA, et al.Neonatal sepsis workups in infants >/=2000

grams at birth: A population-based study.Pediatrics. 2000;106(2 pt 1):256–263

20. Buckler B, Bell J, Sams R, et al. Unnecessaryworkup of asymptomatic neonates in theera of group B streptococcus prophylaxis[published online ahead of print August 22,2010]. Infect Dis Obstet Gynecol. doi:

21. Ottolini MC, Lundgren K, Mirkinson LJ,Cason S, Ottolini MG. Utility of completeblood count and blood culture screening todiagnose neonatal sepsis in the asymp-tomatic at risk newborn. Pediatr Infect DisJ. 2003;22(5):430–434

22. Gerdes JS. Clinicopathologic approach tothe diagnosis of neonatal sepsis. Clin Per-inatol. 1991;18(2):361–381

23. Schelonka RL, Chai MK, Yoder BA, Hensley D,Brockett RM, Ascher DP. Volume of bloodrequired to detect common neonatal patho-gens. J Pediatr. 1996;129(2):275–278

24. Dietzman DE, Fischer GW, Schoenknecht FD.Neonatal Escherichia coli septicemia—bacterial counts in blood. J Pediatr. 1974;85(1):128–130

25. Kellogg JA, Ferrentino FL, Goodstein MH,Liss J, Shapiro SL, Bankert DA. Frequency oflow level bacteremia in infants from birthto two months of age. Pediatr Infect Dis J.1997;16(4):381–385

26. Neal PR, Kleiman MB, Reynolds JK, Allen SD,Lemons JA, Yu PL. Volume of blood sub-mitted for culture from neonates. J ClinMicrobiol. 1986;24(3):353–356

27. Connell TG, Rele M, Cowley D, Buttery JP,Curtis N. How reliable is a negative bloodculture result? Volume of blood submittedfor culture in routine practice in a children’shospital. Pediatrics. 2007;119(5):891–896

28. Pourcyrous M, Korones SB, Bada HS, Patter-son T, Baselski V. Indwelling umbilical arte-rial catheter: a preferred sampling site forblood culture. Pediatrics. 1988;81(6):821–825

29. Anagnostakis D, Kamba A, Petrochilou V,Arseni A, Matsaniotis N. Risk of infection





associated with umbilical vein catheterization.A prospective study in 75 newborn infants.J Pediatr. 1975;86(5):759–765

30. Polin JI, Knox I, Baumgart S, Campman E,Mennuti MT, Polin RA. Use of umbilical cordblood culture for detection of neonatal bac-teremia. Obstet Gynecol. 1981;57(2):233–237

31. Visser VE, Hall RT. Urine culture in theevaluation of suspected neonatal sepsis.J Pediatr. 1979;94(4):635–638

32. Vasan U, Lim DM, Greenstein RM, Raye JR.Origin of gastric aspirate polymorphonuclearleukocytes in infants born after prolongedrupture of membranes. J Pediatr. 1977;91(1):69–72

33. Mims LC, Medawar MS, Perkins JR, GrubbWR. Predicting neonatal infections by evalu-ation of the gastric aspirate: a study in twohundred and seven patients. Am J ObstetGynecol. 1972;114(2):232–238

34. Choi Y, Saha SK, Ahmed AS, et al. Routineskin cultures in predicting sepsis pathogensamong hospitalized preterm neonates inBangladesh. Neonatology. 2008;94(2):123–131

35. Evans ME, Schaffner W, Federspiel CF, CottonRB, McKee KT, Jr, Stratton CW. Sensitivity,specificity, and predictive value of bodysurface cultures in a neonatal intensivecare unit. JAMA. 1988;259(2):248–252

36. Sherman MP, Goetzman BW, Ahlfors CE,Wennberg RP. Tracheal asiration and itsclinical correlates in the diagnosis ofcongenital pneumonia. Pediatrics. 1980;65(2):258–263

37. Srinivasan HB, Vidyasagar D. Endotrachealaspirate cultures in predicting sepsis inventilated neonates. Indian J Pediatr. 1998;65(1):79–84

38. Johnson CE, Whitwell JK, Pethe K, Saxena K,Super DM. Term newborns who are at riskfor sepsis: are lumbar punctures necessary?Pediatrics. 1997;99(4). Available at: www.pediatrics.org/cgi/content/full/99/4/e10

39. Eldadah M, Frenkel LD, Hiatt IM, Hegyi T.Evaluation of routine lumbar punctures innewborn infants with respiratory distresssyndrome. Pediatr Infect Dis J. 1987;6(3):243–246

40. Isaacs D, Barfield CP, Grimwood K, McPheeAJ, Minutillo C, Tudehope DI; Australian StudyGroup for Neonatal Infections. Systemicbacterial and fungal infections in infantsin Australian neonatal units. Med J Aust.1995;162(4):198–201

41. May M, Daley AJ, Donath S, Isaacs D; Aus-tralasian Study Group for Neonatal Infec-tions. Early onset neonatal meningitis inAustralia and New Zealand, 1992–2002. ArchDis Child Fetal Neonatal Ed. 2005;90(4):F324–F327

42. Stoll BJ, Hansen N, Fanaroff AA, et al. To tapor not to tap: high likelihood of meningitiswithout sepsis among very low birth weightinfants. Pediatrics. 2004;113(5):1181–1186

43. Garges HP, Moody MA, Cotten CM, et al.Neonatal meningitis: what is the correlationamong cerebrospinal fluid cultures, bloodcultures, and cerebrospinal fluid parame-ters? Pediatrics. 2006;117(4):1094–1100

44. Shah SS, Ebberson J, Kestenbaum LA, HodinkaRL, Zorc JJ. Age-specific reference values forcerebrospinal fluid protein concentration inneonates and young infants. J Hosp Med.2011;6(1):22–27

45. Byington CL, Kendrick J, Sheng X. Normativecerebrospinal fluid profiles in febrile in-fants. J Pediatr. 2011;158(1):130–134

46. Ahmed A, Hickey SM, Ehrett S, et al. Cere-brospinal fluid values in the term neonate.Pediatr Infect Dis J. 1996;15(4):298–303

47. Bonadio WA, Stanco L, Bruce R, Barry D, SmithD. Reference values of normal cerebrospinalfluid composition in infants ages 0 to 8 weeks.Pediatr Infect Dis J. 1992;11(7):589–591

48. Nascimento-Carvalho CM, Moreno-CarvalhoOA. Normal cerebrospinal fluid values infull-term gestation and premature neo-nates. Arq Neuropsiquiatr. 1998;56(3A):375–380

49. Martín-Ancel A, García-Alix A, Salas S, DelCastillo F, Cabañas F, Quero J. Cerebrospi-nal fluid leucocyte counts in healthy neo-nates. Arch Dis Child Fetal Neonatal Ed.2006;91(5):F357–F358

50. Kestenbaum LA, Ebberson J, Zorc JJ, HodinkaRL, Shah SS. Defining cerebrospinal fluidwhite blood cell count reference values inneonates and young infants. Pediatrics. 2010;125(2):257–264

51. Smith PB, Garges HP, Cotton CM, Walsh TJ,Clark RH, Benjamin DK Jr. Meningitis inpreterm neonates: importance of cerebro-spinal fluid parameters. Am J Perinatol.2008;25(7):421–426

52. Smith PB, Cotten CM, Garges HP, et al. Acomparison of neonatal Gram-negative rodand Gram-positive cocci meningitis. J Per-inatol. 2006;26(2):111–114

53. Greenberg RG, Smith PB, Cotten CM, MoodyMA, Clark RH, Benjamin DK Jr. Traumaticlumbar punctures in neonates: test per-formance of the cerebrospinal fluid whiteblood cell count. Pediatr Infect Dis J. 2008;27(12):1047–1051

54. Kanegaye JT, Nigrovic LE, Malley R, et al;American Academy of Pediatrics, PediatricEmergency Medicine Collaborative ResearchCommittee. Diagnostic value of immatureneutrophils (bands) in the cerebrospinalfluid of children with cerebrospinal fluidpleocytosis. Pediatrics. 2009;123(6). Available

at: www.pediatrics.org/cgi/content/full/123/6/e967

55. Rajesh NT, Dutta S, Prasad R, Narang A. Effectof delay in analysis on neonatal cerebrospinalfluid parameters. Arch Dis Child FetalNeonatal Ed. 2010;95(1):F25–F29

56. Christensen RD, Rothstein G, Hill HR, Hall RT.Fatal early onset group B streptococcalsepsis with normal leukocyte counts.Pediatr Infect Dis. 1985;4(3):242–245

57. Engle WD, Rosenfeld CR. Neutropenia inhigh-risk neonates. J Pediatr. 1984;105(6):982–986

58. Manroe BL, Weinberg AG, Rosenfeld CR,Browne R. The neonatal blood count inhealth and disease. I. Reference values forneutrophilic cells. J Pediatr. 1979;95(1):89–98

59. Schelonka RL, Yoder BA, desJardins SE, HallRB, Butler J. Peripheral leukocyte countand leukocyte indexes in healthy newbornterm infants. J Pediatr. 1994;125(4):603–606

60. Mouzinho A, Rosenfeld CR, Sánchez PJ, RisserR. Revised reference ranges for circulatingneutrophils in very-low-birth-weight neonates.Pediatrics. 1994;94(1):76–82

61. Schmutz N, Henry E, Jopling J, ChristensenRD. Expected ranges for blood neutrophilconcentrations of neonates: the Manroeand Mouzinho charts revisited. J Perinatol.2008;28(4):275–281

62. Christensen RD, Rothstein G. Pitfalls in theinterpretation of leukocyte counts of newborninfants. Am J Clin Pathol. 1979;72(4):608–611

63. Lambert RM, Baer VL, Wiedmeier SE, HenryE, Burnett J, Christensen RD. Isolated ele-vated blood neutrophil concentration ataltitude does not require NICU admission ifappropriate reference ranges are used.J Perinatol. 2009;29(12):822–825

64. Christensen RD, Rothstein G. Exhaustion ofmature marrow neutrophils in neonateswith sepsis. J Pediatr. 1980;96(2):316–318

65. Schelonka RL, Yoder BA, Hall RB, et al. Dif-ferentiation of segmented and band neu-trophils during the early newborn period.J Pediatr. 1995;127(2):298–300

66. Lloyd BW, Oto A. Normal values for matureand immature neutrophils in very pretermbabies. Arch Dis Child. 1982;57(3):233–235

67. Gerdes JS, Polin RA. Sepsis screen in neo-nates with evaluation of plasma fibronec-tin. Pediatr Infect Dis J. 1987;6(5):443–446

68. Newman TB, Puopolo KM, Wi S, Draper D,Escobar GJ. Interpreting complete bloodcounts soon after birth in newborns at riskfor sepsis. Pediatrics. 2010;126(5):903–909

69. Rozycki HJ, Stahl GE, Baumgart S. Impairedsensitivity of a single early leukocyte countin screening for neonatal sepsis. PediatrInfect Dis J. 1987;6(5):440–442



70. Manzoni P, Mostert M, Galletto P, et al. Isthrombocytopenia suggestive of organism-specific response in neonatal sepsis?Pediatr Int. 2009;51(2):206–210

71. Guida JD, Kunig AM, Leef KH, McKenzie SE,Paul DA. Platelet count and sepsis in very lowbirth weight neonates: is there an organism-specific response? Pediatrics. 2003;111(6 pt1):1411–1415

72. Vouloumanou EK, Plessa E, KarageorgopoulosDE, Mantadakis E, Falagas ME. Serumprocalcitonin as a diagnostic marker forneonatal sepsis: a systematic review andmeta-analysis. Intensive Care Med. 2011;37(5):747–762

73. Benitz WE. Adjunct laboratory tests in thediagnosis of early-onset neonatal sepsis.Clin Perinatol. 2010;37(2):421–438

74. Gabay C, Kushner I. Acute-phase proteins andother systemic responses to inflammation.N Engl J Med. 1999;340(6):448–454

75. Philip AG. Response of C-reactive proteinin neonatal Group B streptococcal in-fection. Pediatr Infect Dis. 1985;4(2):145–148

76. Benitz WE, Han MY, Madan A, RamachandraP. Serial serum C-reactive protein levels inthe diagnosis of neonatal infection. Pedi-atrics. 1998;102(4). Available at: www.pedi-atrics.org/cgi/content/full/102/4/e41

77. Dandona P, Nix D, Wilson MF, et al. Procalci-tonin increase after endotoxin injection innormal subjects. J Clin Endocrinol Metab.1994;79(6):1605–1608

78. Lapillonne A, Basson E, Monneret G, BienvenuJ, Salle BL. Lack of specificity of procalcitoninfor sepsis diagnosis in premature infants.Lancet. 1998;351(9110):1211–1212

79. Chiesa C, Natale F, Pascone R, et al. C re-active protein and procalcitonin: referenceintervals for preterm and term newbornsduring the early neonatal period. Clin ChimActa. 2011;412(11-12):1053–1059

80. Hayashi Y, Paterson DL. Strategies for re-duction in duration of antibiotic use inhospitalized patients. Clin Infect Dis. 2011;52(10):1232–1240

81. Rodwell RL, Leslie AL, Tudehope DI. Earlydiagnosis of neonatal sepsis using a he-matologic scoring system. J Pediatr. 1988;112(5):761–767

82. Baker CN, Thornsberry C, Facklam RR. Syn-ergism, killing kinetics, and antimicrobialsusceptibility of group A and B streptococci.Antimicrob Agents Chemother. 1981;19(5):716–725

83. MacGowan A, Wootton M, Bowker K, HoltHA, Reeves D. Ampicillin-aminoglycoside in-teraction studies using Listeria monocy-togenes. J Antimicrob Chemother. 1998;41(3):417–418

84. Bryan CS, John JF, Jr, Pai MS, Austin TL.Gentamicin vs cefotaxime for therapy of neo-natal sepsis. Relationship to drug resistance.Am J Dis Child. 1985;139(11):1086–1089

85. Manzoni P, Farina D, Leonessa M, et al. Riskfactors for progression to invasive fungalinfection in preterm neonates with fungalcolonization. Pediatrics. 2006;118(6):2359–2364

86. Bégué P, Floret D, Mallet E, et al. Pharma-cokinetics and clinical evaluation of cefo-taxime in children suffering with purulentmeningitis. J Antimicrob Chemother. 1984;14(suppl B):161–165

87. Nizet V, Klein JO. Bacterial sepsis and men-ingitis. In: Remington JS, Klein JO, WilsonChristopher B, Nizet V, eds. Infectious Dis-eases of the Fetus and Newborn Infant. 7thed. Philadelphia, PA: Saunders; 2010:222–275

88. Pickering LK, Baker CJ, Kimberlin DW, LongSS, eds. Red Book: 2009 Report of theCommittee on Infectious Diseases. 28th ed.Elk Grove Village, IL: American Academy ofPediatrics; 2009

89. Cordero L, Ayers LW. Duration of empiricantibiotics for suspected early-onset sep-sis in extremely low birth weight infants.Infect Control Hosp Epidemiol. 2003;24(9):662–666

90. Cotten CM, Taylor S, Stoll B, et al; NICHDNeonatal Research Network. Prolonged du-ration of initial empirical antibiotic treat-ment is associated with increased rates ofnecrotizing enterocolitis and death forextremely low birth weight infants. Pedi-atrics. 2009;123(1):58–66

91. Kuppala VS, Meinzen-Derr J, Morrow AL,Schibler KR. Prolonged initial empiricalantibiotic treatment is associated with ad-verse outcomes in premature infants.J Pediatr. 2011;159(5):720–725

92. Alexander VN, Northrup V, Bizzarro MJ.Antibiotic exposure in the newborn in-tensive care unit and the risk of necrotiz-ing enterocolitis. J Pediatr. 2011;159(3):392–397

93. Centers for Disease Control and Prevention.Prevention of perinatal group B strepto-coccal disease—revised guidelines fromCDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1–36





DOI: 10.1542/peds.2012-0541; originally published online April 30, 2012; 2012;129;1006Pediatrics

Richard A. Polin and the COMMITTEE ON FETUS AND NEWBORNSepsis

Management of Neonates With Suspected or Proven Early-Onset Bacterial

ServicesUpdated Information &

htmlhttp://pediatrics.aappublications.org/content/129/5/1006.full.including high resolution figures, can be found at:

References

html#ref-list-1http://pediatrics.aappublications.org/content/129/5/1006.full.at:This article cites 90 articles, 33 of which can be accessed free

Subspecialty Collections

_on_fetus__newbornhttp://pediatrics.aappublications.org/cgi/collection/committeeCommittee on Fetus & Newborn

_and_newbornhttp://pediatrics.aappublications.org/cgi/collection/prematurePremature & Newbornthe following collection(s):This article, along with others on similar topics, appears in

Permissions & Licensing

tmlhttp://pediatrics.aappublications.org/site/misc/Permissions.xhtables) or in its entirety can be found online at: Information about reproducing this article in parts (figures,

Reprints http://pediatrics.aappublications.org/site/misc/reprints.xhtml

Information about ordering reprints can be found online:

rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.Grove Village, Illinois, 60007. Copyright © 2012 by the American Academy of Pediatrics. All and trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elkpublication, it has been published continuously since 1948. PEDIATRICS is owned, published, PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly



http://pediatrics.aappublications.org/content/129/5/1006.full.html#ref-list-1

http://pediatrics.aappublications.org/cgi/collection/premature_and_newborn

http://pediatrics.aappublications.org/cgi/collection/committee_on_fetus__newborn

http://pediatrics.aappublications.org/site/misc/Permissions.xhtml

http://pediatrics.aappublications.org/site/misc/reprints.xhtml
